Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cardiovascular effects of infusion of lidocaine on patients with heart disease.

× No keyword cloud information.

12 in total

1. Timing of injection and plasma concentration of lidocaine before endotracheal intubation.

Authors: M Okuda; Y Ohi; M Kurata; M Muneyuki
Journal: J Anesth Date: 1990-04 Impact factor: 2.078

2. Effects of intravenous or endotracheal lidocaine on circulatory changes during recovery from general anesthesia.

Authors: M Okuda; K Furuhashi; K Konishi; M Muneyuki
Journal: J Anesth Date: 1990-10 Impact factor: 2.078

3. Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial.

Authors: Peter J Kudenchuk; Siobhan P Brown; Mohamud Daya; Laurie J Morrison; Brian E Grunau; Tom Rea; Tom Aufderheide; Judy Powell; Brian Leroux; Christian Vaillancourt; Jonathan Larsen; Lynn Wittwer; M Riccardo Colella; Shannon W Stephens; Mark Gamber; Debra Egan; Paul Dorian
Journal: Am Heart J Date: 2014-03-01 Impact factor: 4.749

4. Effects of tocainide on left ventricular performance at rest and during acute alterations in heart rate and systemic arterial pressure. An echocardiographic study.

Authors: W F Ryan; J S Karliner
Journal: Br Heart J Date: 1979-02

5. Controlled trial of prophylatic treatment with lidocaine in acute myocardial infarction.

Authors: W Bleifeld; K W Merx; K W Heinrich; S Effert
Journal: Eur J Clin Pharmacol Date: 1973-08 Impact factor: 2.953

6. Antiarrhythmic agents. II. Therapeutic considerations.

Authors: D T Mason; A N DeMaria; E A Amsterdam; R Zelis; R A Massumi
Journal: Drugs Date: 1973 Impact factor: 9.546

7. Haemodynamic effects of class I antiarrhythmic agents.

Authors: V Legrand; P Collignon
Journal: Drugs Date: 1985 Impact factor: 9.546

Review 8. Clinical pharmacokinetics of lignocaine.

Authors: N L Benowitz; W Meister
Journal: Clin Pharmacokinet Date: 1978 May-Jun Impact factor: 6.447

9. Observations on intravenous administration of lignocaine in patients with myocardial infarction.

Authors: N P Campbell; J G Kelly; A A Adgey; D G McDevitt; J F Pantridge
Journal: Br Heart J Date: 1978-12

10. Effect of lignocaine on arginine-vasopressin plasma levels: baseline or induced by frusemide.

Authors: L Gariépy; P Larose; B Bailey; P du Souich
Journal: Br J Pharmacol Date: 1992-06 Impact factor: 8.739